146 related articles for article (PubMed ID: 22274916)
1. Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia.
Kucukgoz Gulec U; Paydas S; Guzel AB; Buyukkurt S; Seydaoglu G; Vardar MA
Med Oncol; 2012 Dec; 29(4):2937-43. PubMed ID: 22274916
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.
Yüce K; Baykal C; Genç C; Al A; Ayhan A
Eur J Gynaecol Oncol; 2001; 22(3):228-32. PubMed ID: 11501779
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
[TBL] [Abstract][Full Text] [Related]
5. Significance of serum and peritoneal fluid lactate dehydrogenase levels in ovarian cancer.
Boran N; Kayikçioğlu F; Yalvaç S; Tulunay G; Ekinci U; Köse MF
Gynecol Obstet Invest; 2000; 49(4):272-4. PubMed ID: 10828712
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal fluid analysis in the differentiation of ovarian cancer and benign ovarian tumor.
Halperin R; Hadas E; Bukovsky I; Schneider D
Eur J Gynaecol Oncol; 1999; 20(1):40-4. PubMed ID: 10422681
[TBL] [Abstract][Full Text] [Related]
8. CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders.
Ismail MA; Rotmensch J; Mercer LJ; Block BS; Salti GI; Holt JA
J Reprod Med; 1994 Jul; 39(7):510-2. PubMed ID: 7966039
[TBL] [Abstract][Full Text] [Related]
9. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF
Cancer; 2001 Dec; 92(11):2837-44. PubMed ID: 11753957
[TBL] [Abstract][Full Text] [Related]
10. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.
Fawzy A; Mohamed MR; Ali MA; Abd El-Magied MH; Helal AM
Asian Pac J Cancer Prev; 2016; 17(1):323-33. PubMed ID: 26838232
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of osteopontin and CA125 in detection of epithelial ovarian carcinoma.
Milivojevic M; Boskovic V; Atanackovic J; Milicevic S; Razic S; Kotlica BK
Eur J Gynaecol Oncol; 2013; 34(1):83-5. PubMed ID: 23590008
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors.
Stefanovic V; Pakarinen P; Alfthan H; Stenman UH; Leminen A; Pociuviene J; Riska A; Loukovaara M
Int J Gynecol Cancer; 2012 Nov; 22(9):1470-3. PubMed ID: 23027039
[TBL] [Abstract][Full Text] [Related]
14. [The value of CA125 and LDH assays in assisting diagnosis of epithelial ovarian carcinoma].
Qie M; Peng Z; Cao Z; Tang Q; He B
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):310-3. PubMed ID: 9389070
[TBL] [Abstract][Full Text] [Related]
15. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
17. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients.
Dalal V; Kumar R; Kumar S; Sharma A; Kumar L; Sharma JB; Roy KK; Singh N; Vanamail P
Clin Chim Acta; 2018 Jul; 482():27-32. PubMed ID: 29572186
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
Lane D; Matte I; Garde-Granger P; Laplante C; Carignan A; Rancourt C; Piché A
BMC Cancer; 2015 Jul; 15():492. PubMed ID: 26122176
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in peritoneal fluid of ovarian neoplasms.
de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
[TBL] [Abstract][Full Text] [Related]
20. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]